Search - tctmd.com

Displaying 61 - 80 of 215

Sort: Relevancy | Date

Presentation TCT 2025

Modern Era and Futuristic Pharmacological Management of Aortic Stenosis: Pre and Post Intervention

Presenter: Chetan Huded

October 26, 2025

Presentation TCT 2025

Addressing Disparities In Aortic Stenosis Management: Have We Made Progress?

Presenter: Wayne Batchelor

October 26, 2025

Presentation TCT 2025

Addressing Undertreatment In Aortic Stenosis: Target AS, Detect AS, and Beyond

Presenter: Sammy Elmariah

October 26, 2025

Presentation TCT 2025

From Detection to Early Intervention: Optimizing Active Surveillance with AHA’s Target: Aortic Stenosis

Presenter: Linda D. Gillam

October 26, 2025

Presentation TCT 2025

TCT 643: Treatment of Aortic Stenosis in Patients with Active Cancer: Lifetime Management Considerations

Presenter: Philipp Kiefer

October 26, 2025

Presentation TCT 2025

TCT 644: Impact of Timing of Aortic Valve Replacement Relative to Cancer Therapy on Clinical Outcomes in Patients With Hematologic Malignancy and Severe Aortic Stenosis: A Real‑World Propensity‑Matched

Presenter: Hasnan M. Ijaz

October 26, 2025

Presentation TCT 2025

TCT 75: Repurposing Transthoracic Echocardiogram Predictors of Cardiac Amyloid to Risk Stratify the Severe Aortic Stenosis Population Referred for TAVR

Presenter: Robert Kay

October 26, 2025

Presentation TCT 2025

TCT 70: Comparative Outcomes of TAVR vs. SAVR in Patients with Cardiac Amyloidosis and Aortic Stenosis: A Retrospective Matched Cohort Study

Presenter: Shayan Khan

October 26, 2025

Presentation TCT 2025

TAVR Device Selection Considerations (SMART)

Presenter: Howard C. Herrmann

October 26, 2025

Presentation TCT 2025

SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA)

Presenter: Marvin H. Eng

October 26, 2025

Presentation TCT 2025

Small Annulus Definitions, Misconceptions, and the Great Divide

Presenter: Rebecca T. Hahn

October 26, 2025

Presentation TCT 2025

The “Reality” of Surgical Aortic Root Enlargement

Presenter: Bo Yang

October 26, 2025

Presentation TCT 2025

Case Presentation

Presenter: Andrea Scotti

October 26, 2025

Presentation TCT 2025

Can We Improve TAVR Durability Today? Imaging-based Procedural Solutions

Presenter: Joao L. Cavalcante

October 26, 2025

Presentation TCT 2025

TCT 1113: Transcatheter versus Surgical Aortic-Valve Replacement in Women with High versus Low Gradient Severe Aortic Stenosis: A Substudy of the RHEIA Trial

Presenter: Philippe Pibarot

October 26, 2025

Presentation TCT 2025

Can We Delay AS Progression Tomorrow: Pharmacological Therapy

Presenter: Philippe Pibarot

October 26, 2025

Presentation TCT 2025

Implications for TAVR-First or SAVR - First Strategies

Presenter: Mayra Guerrero

October 26, 2025

Presentation TCT 2025

PRO – SURGERY: 3 Reasons why Surgery is the Best Option for this Patient

Presenter: Rishi Puri

October 26, 2025

Presentation TCT 2025

PRO – TAVR: 3 Reasons why TAVR is the Best Option for this Patient

Presenter: Michael J. Reardon

October 26, 2025

Presentation TCT 2025

Case Presentation:

Presenter: Pier Pasquale Leone

October 26, 2025

Advertisement

Modern Era and Futuristic Pharmacological Management of Aortic Stenosis: Pre and Post Intervention

Addressing Disparities In Aortic Stenosis Management: Have We Made Progress?

Addressing Undertreatment In Aortic Stenosis: Target AS, Detect AS, and Beyond

From Detection to Early Intervention: Optimizing Active Surveillance with AHA’s Target: Aortic Stenosis

TCT 643: Treatment of Aortic Stenosis in Patients with Active Cancer: Lifetime Management Considerations

TCT 644: Impact of Timing of Aortic Valve Replacement Relative to Cancer Therapy on Clinical Outcomes in Patients With Hematologic Malignancy and Severe Aortic Stenosis: A Real‑World Propensity‑Matched

TCT 75: Repurposing Transthoracic Echocardiogram Predictors of Cardiac Amyloid to Risk Stratify the Severe Aortic Stenosis Population Referred for TAVR

TCT 70: Comparative Outcomes of TAVR vs. SAVR in Patients with Cardiac Amyloidosis and Aortic Stenosis: A Retrospective Matched Cohort Study

TAVR Device Selection Considerations (SMART)

SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA)

Small Annulus Definitions, Misconceptions, and the Great Divide

The “Reality” of Surgical Aortic Root Enlargement

Case Presentation

Can We Improve TAVR Durability Today? Imaging-based Procedural Solutions

TCT 1113: Transcatheter versus Surgical Aortic-Valve Replacement in Women with High versus Low Gradient Severe Aortic Stenosis: A Substudy of the RHEIA Trial

Can We Delay AS Progression Tomorrow: Pharmacological Therapy

Implications for TAVR-First or SAVR - First Strategies

PRO – SURGERY: 3 Reasons why Surgery is the Best Option for this Patient

PRO – TAVR: 3 Reasons why TAVR is the Best Option for this Patient

Case Presentation:

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content